A study just published in the journal Microbiome, describes for the first time the intestinal microbiome and metabolome in patients with (genetically acquired) CTLA4 deficiency. CTLA4 is an immune checkpoint, a key element in cancer mechanisms whose discovery has revolutionized the field.
Leave A Comment